Scripps Research Institute
- Assets
- $1.2b
- Revenue
- $537.1m
- Investments
- $223.1m
- Employees
- 2,160
- Location
- La Jolla, CA
- Founding
- 01/1991
- Data as of
- 09/2021
- EIN
- 33-0435954
Organization Overview
Scripps Research Institute is located in La Jolla, CA. The organization was established in 1991. According to its NTEE Classification (H92) the organization is classified as: Biomedicine & Bioengineering Research, under the broad grouping of Medical Research and related organizations. As of 09/2021, Scripps Research Institute employed 2,160 individuals. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Scripps Research Institute is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 09/2021, Scripps Research Institute generated $537.1m in total revenue. This represents relatively stable growth, over the past 6 years the organization has increased revenue by an average of 7.5% each year. All expenses for the organization totaled $473.8m during the year ending 09/2021. While expenses have increased by 4.5% per year over the past 6 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Since 2021, Scripps Research Institute has awarded 91 individual grants totaling $67,280,843. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990T
Mission & Program ActivityExcerpts From the 990T Filing
TAX YEAR
2021
Describe the Organization's Mission:
Part 3 - Line 1
TSRI CONDUCTS BIOMEDICAL AND BIOCHEMICAL RESEARCH AND POSTGRADUATE TRAINING PROGRAMS.
Describe the Organization's Program Activity:
GROUNDBREAKING SCIENTIFIC RESEARCH IS CONDUCTED AT TSRI CAMPUSES IN LA JOLLA, CALIFORNIA, AND JUPITER, FLORIDA, SUPPORTED BY GRANTS, CONTRACTS AND FELLOWSHIPS FROM PUBLIC AND PRIVATE INSTITUTES AND INDIVIDUALS. TSRI'S UNIQUE STRUCTURE MERGES BASIC SCIENTIFIC STUDIES IN BIOLOGY, CHEMISTRY AND BIOINFORMATICS WITH TRANSLATIONAL SCIENCE TO PRODUCE THE NEXT GENERATION OF DRUGS AND ADVANCES IN DIGITAL AND PRECISION MEDICINE. SCIENTIFIC DISCOVERIES AT TSRI SEED JOINT DRUG DISCOVERY PROJECTS AT CALIBR, A DIVISION OF TSRI, CREATING A PIPELINE OF DRUG CANDIDATES THAT WILL IMPACT PATIENTS FOR YEARS TO COME. THE SCRIPPS RESEARCH TRANSLATIONAL INSTITUTE, ANOTHER DIVISION OF TSRI, AIMS TO INDIVIDUALIZE HEALTHCARE BY LEVERAGING THE PROGRESS BEING MADE IN HUMAN GENOMICS AND COMBINING IT WITH THE POWER OF WIRELESS DIGITAL TECHNOLOGIES AND ARTIFICIAL INTELLIGENCE.
TSRI IS COMMITTED TO EDUCATING, TRAINING AND INSPIRING THE SCIENTISTS OF TOMORROW. THE INSTITUTE'S SKAGGS GRADUATE SCHOOL OF CHEMICAL AND BIOLOGICAL SCIENCES, RANKED ONE OF THE TEN BEST GRADUATE PROGRAMS IN THE COUNTRY, EMPOWERS STUDENTS TO MAKE HIGH-IMPACT DISCOVERIES AT THE INTERFACE OF CHEMISTRY AND BIOLOGY. STUDENTS IN THE SKAGGS GRADUATE SCHOOL ARE IMMERSED IN INTENSIVE LABORATORY RESEARCH FROM DAY ONE AND PURSUE AMBITIOUS INVESTIGATIONS ACROSS SCIENTIFIC DISCIPLINES. GRADUATES OF THE SCHOOL BECOME EDUCATORS AT TOP UNIVERSITIES AND RESEARCH INSTITUTES, THOUGHT LEADERS WITHIN GOVERNMENT DEPARTMENTS AND INNOVATORS AT PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES. POSTDOCTORAL ASSOCIATES ARRIVE AT TSRI FROM ALL OVER THE GLOBE, SEEKING TO EXPAND THEIR KNOWLEDGE AND TRAINING BY WORKING ALONGSIDE OUR WORLD-RENOWNED SCIENTISTS. THE SCRIPPS FELLOWS PROGRAM IDENTIFIES INDIVIDUALS WITH AN OUTSTANDING RECORD OF GRADUATE RESEARCH AND MOVES THEM INTO THEIR OWN LABORATORIES, ALLOWING THEM TO LEAPFROG THEIR POSTDOCTORAL YEARS OF STUDY AND BEGIN PUSHING THE FRONTIERS OF SCIENTIFIC DISCOVERY.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Eric Topol Professor/exec VP | 40 | $1,057,873 | |
Peter G Schultz President/ceo | OfficerTrustee | 40 | $936,779 |
Matthew S Tremblay Chief Operating Officer | Officer | 40 | $619,874 |
James R Williamson VP Rsch & Academic Affairs | Officer | 40 | $426,678 |
Pamela Garzone Chief Medical Officer | 40 | $404,594 | |
Vadim Klyushnichenko VP Pharmaceutical Dev & Qual | 40 | $397,030 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Wilson Sonsini Goodrich & Rosati Legal Services | 9/29/21 | $256,929 |
Schwegman Lundberg Woessner Pa Legal Services | 9/29/21 | $540,597 |
Deloitte & Touche Llp Audit & Tax Services | 9/29/21 | $432,477 |
Cooley Llp Legal Services | 9/29/21 | $361,152 |
Behmer & Blackford Llp Legal Services | 9/29/21 | $513,719 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $272,180,680 |
| All other contributions, gifts, grants, and similar amounts not included above | $146,510,396 |
| Noncash contributions included in lines 1a–1f | $2,088,733 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $418,691,076 |
| Total Program Service Revenue | $2,261,518 |
| Investment income | $2,706,277 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $73,615,553 |
| Net Rental Income | $92,037 |
| Net Gain/Loss on Asset Sales | $36,716,246 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $537,087,759 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $67,286,299 |
| Grants and other assistance to domestic individuals. | $14,029,323 |
| Grants and other assistance to Foreign Orgs/Individuals | $1,208,354 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $4,764,214 |
| Compensation of current officers, directors, key employees. | $3,881,577 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $178,350,856 |
| Pension plan accruals and contributions | -$10,884,019 |
| Other employee benefits | $32,002,278 |
| Payroll taxes | $13,130,600 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $0 |
| Fees for services: Accounting | $0 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $49,821,370 |
| Advertising and promotion | $0 |
| Office expenses | $3,618,331 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $8,884,814 |
| Travel | $900,048 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $1,897,469 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $30,825,705 |
| Insurance | $3,622,938 |
| All other expenses | $0 |
| Total functional expenses | $473,843,953 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $196,423,177 |
| Pledges and grants receivable | $73,942,523 |
| Accounts receivable, net | $483,949 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $1,184,571 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $23,170,563 |
| Net Land, buildings, and equipment | $301,968,082 |
| Investments—publicly traded securities | $291,006,964 |
| Investments—other securities | $223,115,953 |
| Investments—program-related | $0 |
| Intangible assets | $530,000 |
| Other assets | $48,362,822 |
| Total assets | $1,160,188,604 |
| Accounts payable and accrued expenses | $79,866,253 |
| Grants payable | $0 |
| Deferred revenue | $166,769,573 |
| Tax-exempt bond liabilities | $24,615,041 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $106,075,000 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $60,854,313 |
| Total liabilities | $438,180,180 |
| Net assets without donor restrictions | $448,091,646 |
| Net assets with donor restrictions | $273,916,778 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $1,160,188,604 |
Grants Awarded
Over the last fiscal year, Scripps Research Institute has awarded $67,280,843 in support to 91 organizations.
| Grant Recipient | Amount |
|---|---|
New York, NY PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $8,917,467 |
CAREEVOLUTION PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $7,066,593 |
DEDALUS HEALTHCARE SYSTEMS GROUP PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $5,631,729 |
Seattle, WA PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $2,756,879 |
Atlanta, GA PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $2,700,495 |
WEB MD PURPOSE: GRANTS FOR SCIENTIFIC RESEARCH | $2,385,000 |
Grants Recieved
Over the last fiscal year, we have identified 2 grants that Scripps Research Institute has recieved totaling $127,500.
| Awarding Organization | Amount |
|---|---|
Mackenzies Mission Great Falls, VA PURPOSE: Support of amyloidosis research. | $125,000 |
Washakie Foundation Wilmington, DE PURPOSE: GENERAL & UNRESTRICTED | $2,500 |
Endowment Analysis
| Beg. Balance | $124,417,627 |
| Earnings | $1,930,910 |
| Net Contributions | $22,228,447 |
| Other Expense | $665,936 |
| Ending Balance | $147,911,048 |
Peer Organizations
| Organization Name | Assets | Revenue |
|---|---|---|
Scripps Research Institute La Jolla, CA | $1,160,188,604 | $537,087,759 |
Sanford Burnham Prebys Medical Discovery Institute La Jolla, CA | $307,274,683 | $116,730,403 |
Gary And Mary West Health Institute La Jolla, CA | $20,819,217 | $21,045,299 |
Alfred E Mann Institute For Biomedical Engineering At The Usc Los Angeles, CA | $265,159,414 | $78,284,269 |
Fogarty Institute For Innovation Mountain View, CA | $12,713,454 | $3,362,432 |
Sens Foundation Inc Mountain View, CA | $3,998,305 | $4,002,442 |
Southern California Institute For Research And Education Long Beach, CA | $7,387,710 | $3,555,949 |
Brentwood Biomedical Research Institute Institute Inc Los Angeles, CA | $0 | $493,229 |
Applied Biomedical Science Institute San Diego, CA | $1,308,035 | $2,682,413 |
Agouron Institute Pasadena, CA | $18,754,799 | $1,205,799 |
Beckman Laser Institute Inc Irvine, CA | $7,260,993 | $551,556 |
Biomedical Research Foundation Of Southern Arizona Tucson, AZ | $586,510 | $271,565 |